ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 160 filers reported holding ARRAY BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $4,641,000 | -14.9% | 1,099,801 | -8.1% | 0.03% | -20.0% |
| Q3 2015 | $5,456,000 | -52.1% | 1,196,500 | -24.3% | 0.04% | -47.8% |
| Q2 2015 | $11,402,000 | -4.5% | 1,581,500 | -2.4% | 0.07% | -2.9% |
| Q1 2015 | $11,939,000 | +94.2% | 1,620,000 | +24.6% | 0.07% | +97.1% |
| Q4 2014 | $6,149,000 | +1422.0% | 1,300,000 | +1900.0% | 0.04% | +1066.7% |
| Q3 2013 | $404,000 | -0.5% | 65,000 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $406,000 | – | 65,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |